Home › NDC Lookup › RxCUI directory › RxCUI 2645112

0.1 ML avacincaptad pegol 20 MG/ML Injection — RxCUI 2645112

RxNorm drug concept · Semantic clinical drug
RxCUI 2645112 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2645112
Official name0.1 ML avacincaptad pegol 20 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asavacincapted pegol 2 MG per 0.1 ML Injection; avacincapted pegol 2 MG in 0.1 ML Injection
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)4,306 prescriptions · 30 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Avacincaptad Pegol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats geographic atrophy secondary to age-related macular degeneration. This is a condition where parts of the retina waste away over time. The medicine was shown to slow the g...
  • You don't take it at home. A qualified physician injects it into your eye about once a month. Your eye is numbed and cleaned first, and your eye pressure is checked.
  • The most common are bleeding on the white of the eye, higher eye pressure, blurred vision, eye pain, and floaters. Some people also develop wet AMD, so your doctor will watch for i...
  • Call right away if you have eye pain, redness, sensitivity to light, or blurred vision after your injection. These could signal a serious infection or retinal detachment. Don't wai...
📖 Read our full Avacincaptad Pegol guide →

🕸️ Concept Web — How 0.1 ML avacincaptad pegol 20 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 0.1 ML avacincaptad pegol 20 MG/ML Injection RxCUI 2645112

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Avacincaptad pegol 2645108
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Izervay 2645114
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Avacincaptad pegol Injection 2645111
    • Avacincaptad pegol Injectable Product 2645110
    • Avacincaptad pegol Injection [Izervay] 2645117
    • Izervay Injectable Product 2645116
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Avacincaptad pegol 20 MG/ML SCDC · 2645109
  • Avacincaptad pegol Injection SCDF · 2645111
  • Avacincaptad pegol Injectable Product SCDG · 2645110

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2645112 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
82829-0002-01 1 VIAL, SINGLE-DOSE in 1 CARTON (82829-002-01) / .35 mL in... IZERVAY Astellas Pharma US, Inc. 2023-08-19
82829-0002-99 1 VIAL, SINGLE-DOSE in 1 CARTON (82829-002-99) / .35 mL in... IZERVAY Astellas Pharma US, Inc. 2023-08-19
Observed labelers: Astellas Pharma US, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J2782 Inj avacincaptad pegol 0.1mg 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.